Disialoganglioside GD3 is selectively expressed by developing and mature human mast cells

Journal of Allergy and Clinical Immunology

Volumn 107, Issue 2, 2001, Pages 322-330

  Ren, Shunlin ^a   Kambe, Naotomo ^a   Du, Zhongmin ^a   Li, Yongli ^a   Xia, Han Zhang ^a   Kambe, Michiyo ^a   Bieberich, Erhard ^a   Pozez, Andrea ^a   Grimes, Margaret ^a   Yu, Robert K ^a   Irani, Anne Marie ^a   Schwartz, Lawrence B ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

GD3; Kit; Mast cells; Tryptase

Indexed keywords

GANGLIOSIDE GD3; TRYPTASE;

ANTIBODY AFFINITY; ARTICLE; CELL MATURATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MAST CELL; MELANOMA; PRIORITY JOURNAL;

EID: 0035116781     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.112272     Document Type: Article

References (45)

1. Induction of cholinergic differentiation with neurite sprouting by de novo biosynthesis and expression of GD3 and b-series gangliosides in Neuro2a cells
2. Regulation of glycolipid synthesis in HL-60 cells by antisense oligodeoxynucleotides to glycosyltransferase sequences: Effect on cellular differentiation
3. Inhibition of anti-GD3-ganglioside antibody-induced proliferation of human CD8+ T cells by CD16+ natural killer cells
4. Increased proliferation, cytotoxicity, and gene expression after stimulation of human peripheral blood T Iymphocytes through a surface ganglioside (GD3)
5. Anti-GD3 antibodies are potent activators of human gamma/delta and alpha/beta positive T cells
6. Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis
7. T cell activation via the disialoganglioside GD3: Analysis of signal transduction
8. A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanoma
9. Immunological response to intrathecal and systemic treatment with ganglioside antibody R-24 in patients with malignant melanoma
10. Biological study of R24 mouse monoclonal antibody in patients undergoing thoracotomy for pulmonary metastases from soft tissue sarcoma
11. TC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies
12. Monoclonal antibody YB5.B8 identifies the human c-kit protein product
13. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells
14. Phenotypic characterization of stem cell factor-dependent human foetal liver-derived mast cells
15. GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody
16. Effect of recombinant human IL-4 on tryptase, chymase, and Fcε receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells
17. Recombinant human (rh)IL-4-mediated apoptosis and recombinant human IL-6-mediated protection of recombinant human stem cell factor-dependent human mast cells derived from cord blood mononuclear cell progenitors
18. Quantitation of tryptase, chymase, FcεRIα, and FcεRIgamma mRNAs in human mast cells and basophils by competitive reverse transcriptionpolymerase chain reaction
19. Quantitation of histamine, tryptase and chymase in dispersed human T and TC mast cells
20. Purification of human basophils by density and size alone
21. Establishment of an immature mast cell line from a patient with mast cell leukemia
22. A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors
23. Glycosphingolipids in Bomirski transplantable melanomas in hamsters
24. A simple method for the isolation and purification of total lipids from animal tissues
25. Development regulation of ganglioside metabolism
26. A reappraisal of ganglioside GD3 expression in the CNS
27. Tissue distribution of GD3 ganglioside detected by mouse monoclonal antibody R24
28. Common phenotypic expression of gangliosides GM3 and GD3 in normal human tissues and neoplastic skin lesions
29. Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: A phase I trial in patients with malignant melanoma
30. Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: Induction of inflammatory responses at tumor sites
31. Ganglioside expression in lung cancer cell lines
32. 7-O-acetyl-GD3 in human T-lymphocytes is detected by a specific T-cell-activating monoclonal antibody
33. R24 anti-GD3 ganglioside antibody can induce costimulation and prevent the induction of alloantigen-specific T cell clonal anergy
34. Coexpression of GD3 ganglioside with CD45RO in resting and activated human T lymphocytes
35. Anti-GD3 monoclonal antibody analysis of childhood T-cell acute lymphoblastic leukemia: Detection of a target antigen for antibody-mediated cytolysis
36. Immunoreactivity of leukemic lymphoblasts of T-cell and B-cell precursor origin with monoclonal anti-GD3 and anti-GM3 antibodies
37. Acidic sphingomyelinase (ASM) is necessary for fas-induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells
38. Ganglioside GM3 inhibits interleukin-3-dependent bone marrow-derived mast cell proliferation
39. Binding of monoclonal antibody AA4 to gangliosides on rat basophilic leukemia cells produces changes similar to those seen with Fcε receptor activation
40. 1b in rat basophilic leukemia RBL-2H3 cells
41. The anti-ganglioside monoclonal antibody AA4 induces protein tyrosine phosphorylations, but not degranulation, in rat basophilic leukemia cells
42. Anti-ganglioside monoclonal antibody AA4 selectively inhibits IgE-induced signal transduction pathways in rat basophilic leukemia cells
43. Influence of glycosphingolipids on the release of histamine and sulfidopeptide leukotrienes from human basophils
44. Gangliosides enhance IgE receptor-dependent histamine and LTC4 release from human mast cells
45. Alterations in ganglioside expression during the differentiation of human mast cells